What is the treatment algorithm for the intensive group in the SPRINT research trial?
At randomization visit, begin with 2- or 3-drug therapy using a combination of a thiazide-type diuretic, and/or an ACEI or ARB (but not both) and/or a CCB Include -blocker or other agents as appropriate for compelling indication. Monitor as designated through follow-up. If SBP is 120 mm Hg this visit and DBP is 100 mm Hg at this visit or DBP is 90 mm Hg on last 2 visits and this is a milepost visit, add therapy not already in use and see participant monthly until SBP is <120 mm Hg. If SBP is not 120 mm Hg this visit, titrate or add therapy not already in use and see participant monthly until SBP is <120 mm Hg. If SBP is 120 mm Hg this visit, continue therapy.